Stock futures climbed on Wednesday, driven by strong performances from Salesforce and Marvell Technology, following…
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial…
I had no idea the Fed could be such expert wafflers. But, as each month…
A 9-year-old girl pushes back against period shame, telling adults at the dinner table, “more…
latest news
-
-
When running my StockCharts Technical Rank (SCTR) scan on Thursday, I was a little surprised…
-
The Yield Curve The RRG above shows the rotations of the various maturities on the…
-
Uncertainty in the stock market makes it difficult to make investment decisions. When investors sell…
-
Ukrainian President Volodymyr Zelensky had a tart response to Russian President Vladimir Putin’s annual year-end…
-
Former Syrian regime security forces have been handing in their weapons to the rebel-linked transitional…
-
Investing
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative…
-
Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) (‘Forum’ or the ‘Company’) announced today that…
